Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection

Gut

Volumn 61, Issue 7, 2012, Pages 1076-1084

  Missale, Gabriele ^a   Pilli, Massimo ^a   Zerbini, Alessandro ^b   Penna, Amalia ^a   Ravanetti, Lara ^a   Barili, Valeria ^a   Orlandini, Alessandra ^a   Molinari, Atim ^a   Fasano, Massimo ^c   Santantonio, Teresa ^d   Ferrari, Carlo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; RIBAVIRIN;

ACUTE HEPATITIS; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MALE; MEMORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR BLOCKING; TREATMENT RESPONSE; VIRAL CLEARANCE;

ANTIVIRAL AGENTS; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; MALE; PROGRAMMED CELL DEATH 1 RECEPTOR; RIBAVIRIN; VIRAL LOAD;

EID: 84861579810     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300515     Document Type: Article

References (35)

1. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36:S35-46. (Pubitemid 35253462)
2. Kamal SM. Acute hepatitis C: a systematic review. Am J Gastroenterol 2008;103:1283-97. (Pubitemid 351677997)
3. Bialek SR, Terrault NA. The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 2006;10:697-715. (Pubitemid 44880154)
4. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-29. (Pubitemid 40364823)
5. Asselah T, Bièche I, Sabbagh A, et al. Gene expression and hepatitis C virus infection. Gut 2009;58:846-58.
6. Klenerman P, Hill A. T-cells and viral persistence: lessons from diverse infections. Nat Immunol 2005;6:873-9. (Pubitemid 43090441)
7. Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T-cells during chronic viral infection. Nature 2006;439:682-7. (Pubitemid 43237609)
8. Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335-74.
9. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-82.
10. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958-65. (Pubitemid 32913521)
11. Gruner NH, Gerlach TJ, Jung MC, et al. Association of hepatitis C virus-specific CD8+ T-cells with viral clearance in acute hepatitis C. J Infect Dis 2000;181:1528-36. (Pubitemid 30387741)
12. Penna A, Pilli M, Zerbini A, et al. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 2007;45:588-601. (Pubitemid 46450610)
13. Urbani S, Amadei B, Tola D, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 2006;80:11398-403. (Pubitemid 44706581)
14. Kim PS, Ahmed R. Features of responding T-cells in cancer and chronic infection. Curr Opin Immunol 2010;22:223-30.
15. Abdel-Hakeem MS, Bédard N, Badr G, et al. Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus. J Virol 2010;84:10429-35.
16. Youngblood B, Oestreich KJ, Ha SJ, et al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity 2011;35:400-12.
17. Wherry EJ, Blattman JN, Murali-Krishna K, et al. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003;77:4911-27. (Pubitemid 36402840)
18. Fuller MJ, Khanolkar A, Tebo AE, et al. Maintenance, loss, and resurgence of T-cell responses during acute, protracted, and chronic viral infections. J Immunol 2004;172:4204-14. (Pubitemid 38375233)
19. Golden-Mason L, Palmer B, Klarquist J, et al. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T-cells associated with reversible immune dysfunction. J Virol 2007;81:9249-58. (Pubitemid 47311467)
20. Boni C, Fisicaro P, Valdatta C, et al. Characterisation of hepatitis B virus (HBV)- specific T-cell dysfunction in chronic HBV infection. J Virol 2007;81:4215-25. (Pubitemid 46586915)
21. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T-cells is associated with T-cell exhaustion and disease progression. Nature 2006;443:350-4. (Pubitemid 44435155)
22. Wherry EJ, Barber DL, Kaech SM, et al. Antigen-independent memory CD8 T-cells do not develop during chronic viral infection. Proc Natl Acad Sci USA 2004;101:16004-9. (Pubitemid 39507917)
23. Wherry EJ, Blattman JN, Ahmed R. Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J Virol 2005;79:8960-8. (Pubitemid 40934807)
24. Golden-Mason L, Burton JR Jr, Castelblanco N, et al. Loss of IL-7 receptor alphachain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology, 2006;44:1098-109. (Pubitemid 44748361)
25. Urbani S, Amadei B, Fisicaro P, et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 2006;44:126-39. (Pubitemid 44049146)
26. Badr G, Bédard N, Abdel-Hakeem MS, et al. Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T-cells. J Virol 2008;82:10017-31.
27. Bowen DG, Shoukry NH, Grakoui A, et al. Variable patterns of programmed death-1 expression on fully functional memory T-cells after spontaneous resolution of hepatitis C virus infection. J Virol 2008;82:5109-14. (Pubitemid 351657073)
28. Kamal SM, Fehr J, Roesler B, et al. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 2002;123:1070-83.
29. Kamal SM, Ismail A, Graham CS, et al. Pegylated-interferon-alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T-cell response kinetics. Hepatology 2004;39:1721-31. (Pubitemid 38702674)
30. Lauer GM, Lucas M, Timm J, et al. Full-breadth analysis of CD8! T-cell responses in acute hepatitis C virus infection and early therapy. J Virol 2005;79:12979-88. (Pubitemid 41433217)
31. Rahman F, Heller T, Sobao Y, et al. Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology 2004;40:87-97. (Pubitemid 38868927)
32. Barnes E, Harcourt G, Brown D, et al. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 2002;36:743-54. (Pubitemid 34977187)
33. Kaplan DE, Sugimoto K, Ikeda F, et al. T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C. Hepatology 2005;41:1365-75. (Pubitemid 40770290)
34. Pilli M, Zerbini A, Penna A, et al. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). Gastroenterology 2007;133:1132-43. (Pubitemid 47494444)
35. Urbani S, Amadei B, Tola D, et al. Restoration of HCV-specific T-cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J Hepatol 2008;48:548-58.